ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
InvAscent-backed Malladi Drugs has selected bankers for a proposed initial public offering. The pharmaceutical company is moving forward with plans to list on the stock market, backed by its private equity investor.
Tap to vote and see what everyone thinks.
Summary by ByteBrief